Temple University Hospital has become the first U.S. center to perform bronchoscopic lung volume reduction using implantation of the Zephyr® Endobronchial Valve (Zephyr® EBV®) to treat severe ...
Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...
WASHINGTON — Patients with emphysema treated with one-way endobronchial values showed consistent improvement in lung function after 5 years compared with controls, based on data from 174 individuals.
(Philadelphia, PA) - Temple University Hospital has become the first U.S. center to perform bronchoscopic lung volume reduction using implantation of the Zephyr® Endobronchial Valve (Zephyr® EBV®) to ...
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx Corporation is announcing that over 20,000 patients have been treated worldwide with their Zephyr® ...
Endobronchial valve management has emerged as a minimally invasive intervention for the treatment of persistent air leaks and fistulas, conditions that are often associated with considerable morbidity ...
"Endobronchial Valves market Share, Size, Trends, industry Analysis Report, By Product Type (Duckbill-Shaped, Umbrella-Shaped); By End User; By Region; Segment Forecast, 2024 - 2032" published by ...
LOS ANGELES—January 26, 2025—As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for advanced emphysema may survive longer and with fewer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback